Centogene: Berndt Modig

Berndt Modig has resigned from Centogene's supervisory board, effective Aug. 15. In a document filed with the US Securities and Exchange Commission, the company said his resignation did not result from any disagreement with Centogene. Modig had announced in November his intention to resign from the firm's supervisory board. Modig is the cofounder and CEO of Pharvaris, a developer of new oral alternatives for people with hereditary angioedema, according to his LinkedIn profile.